Clinical Trial Update: A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and safety study of IV gallium nitrate (Ganite) in cystic fibrosis patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Gallium nitrate (Ganite) (gallium nitrate)

Snippet

Sponsor: University of Washington | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED | Results posted: 2016-01-12